Founded in 2002 in Cartoceto (PU), Italy, Diatheva is a biotechnology company born as a spin-off of the University of Urbino.
70% of its employees hold a PhD and oversee all stages of activity, from research and development to production and finalization.

For 20 years, Diatheva has been engaged in the research, development, and production of:
- Biotechnological products: including monoclonal and polyclonal antibodies, antibody fragments, recombinant proteins, recombinant enzymes, and antigens;
- Molecular and immunoenzymatic tests: such as in vitro diagnostics (IVD), veterinary kits, food analysis kits, and environmental kits.

To achieve these goals, Diatheva collaborates with companies, public and private institutions, operating mainly in the fields of oncology, microbial infections, and pharmacogenetics.

Diatheva operates a state-of-the-art GMP production facility, authorized by AIFA since 2006 for biomolecules (APIs) and since 2023 for medicinal products.